These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11818473)

  • 41. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Tonelli M; Karumanchi SA; Thadhani R
    Circulation; 2016 Feb; 133(5):518-36. PubMed ID: 26831434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of Diabetes Mellitus and Cardiovascular Disease.
    Glovaci D; Fan W; Wong ND
    Curr Cardiol Rep; 2019 Mar; 21(4):21. PubMed ID: 30828746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Link between Diabetes and Cardiovascular Disease: The Epidemiological Perspective.
    Weitzman S
    Isr Med Assoc J; 2016 Dec; 18(12):709-711. PubMed ID: 28457070
    [No Abstract]   [Full Text] [Related]  

  • 44. The mother--the long-term implications on metabolic and cardiovascular complications.
    Lao TT
    Best Pract Res Clin Obstet Gynaecol; 2015 Feb; 29(2):244-55. PubMed ID: 25261964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.
    Diamant M; Tushuizen ME
    Curr Diab Rep; 2006 Aug; 6(4):279-86. PubMed ID: 16879779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.
    Nelson AJ; Peterson ED; Pagidipati NJ
    Prog Cardiovasc Dis; 2019; 62(4):306-314. PubMed ID: 31301314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes-associated cardiovascular risk factors.
    Burden M
    Nurs Stand; 2001 Jul 4-10; 15(42):45-52; quiz 54-5. PubMed ID: 12212431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Microbiota: A New Marker of Cardiovascular Disease.
    Garcia-Rios A; Torres-Peña JD; Perez-Jimenez F; Perez-Martinez P
    Curr Pharm Des; 2017; 23(22):3233-3238. PubMed ID: 28317481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Kahn R; Buse J; Ferrannini E; Stern M
    Diabetologia; 2005 Sep; 48(9):1684-99. PubMed ID: 16079964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative stress biomarkers in type 2 diabetes mellitus for assessment of cardiovascular disease risk.
    Robson R; Kundur AR; Singh I
    Diabetes Metab Syndr; 2018 May; 12(3):455-462. PubMed ID: 29307576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes and coronary risk equivalency: what does it mean?
    Grundy SM
    Diabetes Care; 2006 Feb; 29(2):457-60. PubMed ID: 16443907
    [No Abstract]   [Full Text] [Related]  

  • 52. Small at Birth, but How Small? The Definition of SGA Revisited.
    Zeve D; Regelmann MO; Holzman IR; Rapaport R
    Horm Res Paediatr; 2016; 86(5):357-360. PubMed ID: 27685026
    [No Abstract]   [Full Text] [Related]  

  • 53. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course.
    Huebschmann AG; Huxley RR; Kohrt WM; Zeitler P; Regensteiner JG; Reusch JEB
    Diabetologia; 2019 Oct; 62(10):1761-1772. PubMed ID: 31451872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detecting and managing patients with type 2 diabetic kidney disease: proteinuria and cardiovascular disease.
    Mitch WE; Shahinfar S; Dickson TZ; de Zeeuw D; Zhang Z
    Kidney Int Suppl; 2004 Nov; (92):S97-8. PubMed ID: 15485428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sugar and cardiovascular disease: A statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association.
    Howard BV; Wylie-Rosett J
    Circulation; 2002 Jul; 106(4):523-7. PubMed ID: 12135957
    [No Abstract]   [Full Text] [Related]  

  • 56. Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.
    Schnell O; Standl E; Catrinoiu D; Genovese S; Lalic N; Skra J; Valensi P; Ceriello A
    Cardiovasc Diabetol; 2016 Feb; 15():33. PubMed ID: 26892706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes mellitus and the risk for cardiovascular disease.
    Alpert JS
    Curr Cardiol Rep; 2003 Sep; 5(5):337. PubMed ID: 12917044
    [No Abstract]   [Full Text] [Related]  

  • 58. Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors.
    Meloni A; Cadeddu C; Cugusi L; Donataccio MP; Deidda M; Sciomer S; Gallina S; Vassalle C; Moscucci F; Mercuro G; Maffei S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes to cardiovascular disease: is depression the potential missing link?
    Singh P; Khullar S; Singh M; Kaur G; Mastana S
    Med Hypotheses; 2015 Apr; 84(4):370-8. PubMed ID: 25655224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking.
    Gautier A; Ducrocq G; Elbez Y; Fox KM; Ferrari R; Ford I; Tardif JC; Tendera M; Feldman LJ; Steg PG
    Eur J Prev Cardiol; 2022 Feb; 29(1):e35-e37. PubMed ID: 33624093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.